Sakar Healthcare Limited (SAKAR) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE732S01012
Key metrics
- Market Cap
- ₹2,226 Cr
- P/E Ratio
- 73.47
- EPS
- 13.8
- Book Value
- 145.82
- P/B Ratio
- 6.94
- ROE
- 9.4%
- ROCE
- 11.82%
- Debt / Equity
- 0.22
- Net Margin
- 12.11%
- Revenue Growth
- 41.76%
- Profit Growth
- 74.18%
- Dividend Yield
- —
- 52W High
- ₹1,024.00
- 52W Low
- ₹321.05
- Market Cap Band
- small cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Sakar Healthcare Limited
Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company offers general and oncology products in various forms, such as liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. It also exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.
- Headquarters
- Ahmedabad, India
- Employees
- 435
The full Sakar Healthcare Limited analysis
Create a free account to open the complete SAKAR deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.